[Will inhibition of the hexose monophosphate shunt increase resistance to oxygen deficiency?].
Trojan
S
S
D015120:6-Aminonicotinamide / Q000494:pharmacology*; D000818:Animals; D006112:Gravitation; D006943:Hyperglycemia / Q000503:physiopathology; D007035:Hypothermia / Q000503:physiopathology; D000860:Hypoxia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010427:Pentose Phosphate Pathway / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains
D009536:Niacinamide; D015120:6-Aminonicotinamide
Můze inhibice hexosomonofosfátového zkratu zvýsit odolnost organismu proti nedostatku kyslíku?